The current price of ZURA is $3.72 — it has decreased by 7.46% since the previous close. Data as of Nov 5, 2026.
ZURA is down 2.36% over the past week, down 5.34% over the past month and up 2.48% over the past year. The price is below its 200-day moving average of $5.22.
Analysts' average 12-month price target for ZURA is $20.00, which implies 437.63% upside from the current price. Individual estimates range from $20.00 to $20.00.
Of the 7 analysts covering Zura Bio Limited, 1 rates it a strong buy and 6 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Zura Bio Limited has a market capitalization of $358.33M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Zura Bio Limited posted a loss of $0.20 per share against an estimate of -$0.2039, beating expectations by 1.93%. Upcoming reports are listed in the earnings calendar.
Zura Bio Limited has not paid any dividends over the past year.
Companies most comparable to Zura Bio Limited include Assembly Biosciences, Inc., Sagimet Biosciences Inc., Enanta Pharmaceuticals, Inc., Arcturus Therapeutics Holdings Inc. and Nautilus Biotechnolgy, Inc.
In the latest trading session ZURA moved between $3.70 and $4.01, a range of 8.33% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Zura Bio Limited shows a sell rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Zura Bio Limited is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ZURA has traded between $3.25 and $7.44. The current price is 50.00% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.